RenovaCare (OTCMKTS:RCAR) Stock Crosses Above 50 Day Moving Average – Time to Sell?

RenovaCare Inc. (OTCMKTS:RCARGet Free Report)’s share price passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.00 and traded as high as $0.0001. RenovaCare shares last traded at $0.0001, with a volume of 6,030 shares traded.

RenovaCare Stock Down 50.0%

RenovaCare Company Profile

(Get Free Report)

RenovaCare, Inc is a clinical‐stage regenerative medicine company focused on developing and commercializing products for the treatment of severe skin injuries and chronic wounds. The company’s core technology, the TransForm™ device, is an autologous cell therapy system designed to harvest, process and deliver a patient’s epidermal cells directly to wound sites. By leveraging a proprietary vacuum technology, TransForm™ enables clinicians to create and apply a living skin spray that aims to accelerate healing in acute burns, diabetic foot ulcers and other complex skin defects.

RenovaCare holds a robust patent portfolio covering its TransForm™ platform, which it is advancing through clinical trials and regulatory pathways in the United States.

Featured Stories

Receive News & Ratings for RenovaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RenovaCare and related companies with MarketBeat.com's FREE daily email newsletter.